Vaccinarea poate ajuta mii de tineri s nu se 樽mbolnveasc ,dar cum dac nu tii nimic despre boal?
HPV tulpinile cu risc mare ce provoac cancer de col uterin. Suportul de curs te ajut s 樽nelegi de ce e bine s te vaccinezi. At但t brbaii c但t i femeile se pot vaccina. Vaccinarea ideala este de la v但rsta fragede 樽nainte de a 樽ncepe via sexuala i a 樽ntra 樽n contact cu boala .
Revista Frunza a Asociaiei Medisprof a luat natere ca urmare a nevoii de comunicare intre specialitii clinicii Medisprof i pacieni. In revista vei regsi articole legate de activitile Asociaiei si partenerilor ei i articole din domeniul radioterapiei, nutriiei, psihologiei.
Partenerii oficiali ai Revistei Frunza:
Roche Romania
Oncompass GMBH
Farmacia Vinca
Acupunctura si fitoterapia sunt recunoscute la nivel mondial pentru actiunea benefica asupra psihicului, pentru relaxarea si reechilibrarea afectiva a pacientilor. Eliminand cauzele tensiunii nervoase, la nivelul creierului se intensifica secretia de serotonina, denumita si hormonul fericirii. Prin acest proces se elimina dezechilibrele neuro-endocrine ce au dus la aparitia sterilitatii. In acelasi timp se intensifica si oxigenarea la nivel celular, redusa initial de prezenta tensiunii nervoase. Astfel se elimina hipooxigenarea organismului, se regleaza functiile metabolice si se elimina mediul propice dezvoltarii microorganismelor patogene. In zona genitala, in functie de afectiunile fiecarei paciente, se amelioreaza activitatea ovariana si se echilibreaza secretiile hormonale specifice.
This document summarizes evidence on neuropsychiatric manifestations in COVID-19 survivors ("long COVID"). It finds that depression, anxiety, PTSD, sleep disturbances, fatigue and cognitive deficits are commonly reported neuropsychiatric symptoms. Studies show that months after initial infection, a significant proportion of survivors experience these symptoms. The severity of the initial COVID-19 infection and inflammation are associated with increased risk and severity of neuropsychiatric symptoms over time. However, the pathophysiological mechanisms underlying neuropsychiatric manifestations in long COVID remain incompletely understood.
A 60-year-old man presented with fever, fatigue, loss of appetite, and shortness of breath five days after a previous SARS-CoV-2 infection. He had signs of inflammation in multiple organs including the eyes, tongue, skin, and lungs. Based on his symptoms meeting criteria for multisystem inflammatory syndrome in adults (MIS-A) and Kawasaki disease, he was given treatments including steroids, aspirin, and immunoglobulins, which led to rapid improvement. His case suggests MIS-A, a post-viral inflammatory condition primarily described in children, can also occur in older adults.
More Related Content
Similar to Evaluarea_nivelului_de_educatie_Dr.Elena_Popa.pptx (20)
Revista Frunza a Asociaiei Medisprof a luat natere ca urmare a nevoii de comunicare intre specialitii clinicii Medisprof i pacieni. In revista vei regsi articole legate de activitile Asociaiei si partenerilor ei i articole din domeniul radioterapiei, nutriiei, psihologiei.
Partenerii oficiali ai Revistei Frunza:
Roche Romania
Oncompass GMBH
Farmacia Vinca
Acupunctura si fitoterapia sunt recunoscute la nivel mondial pentru actiunea benefica asupra psihicului, pentru relaxarea si reechilibrarea afectiva a pacientilor. Eliminand cauzele tensiunii nervoase, la nivelul creierului se intensifica secretia de serotonina, denumita si hormonul fericirii. Prin acest proces se elimina dezechilibrele neuro-endocrine ce au dus la aparitia sterilitatii. In acelasi timp se intensifica si oxigenarea la nivel celular, redusa initial de prezenta tensiunii nervoase. Astfel se elimina hipooxigenarea organismului, se regleaza functiile metabolice si se elimina mediul propice dezvoltarii microorganismelor patogene. In zona genitala, in functie de afectiunile fiecarei paciente, se amelioreaza activitatea ovariana si se echilibreaza secretiile hormonale specifice.
This document summarizes evidence on neuropsychiatric manifestations in COVID-19 survivors ("long COVID"). It finds that depression, anxiety, PTSD, sleep disturbances, fatigue and cognitive deficits are commonly reported neuropsychiatric symptoms. Studies show that months after initial infection, a significant proportion of survivors experience these symptoms. The severity of the initial COVID-19 infection and inflammation are associated with increased risk and severity of neuropsychiatric symptoms over time. However, the pathophysiological mechanisms underlying neuropsychiatric manifestations in long COVID remain incompletely understood.
A 60-year-old man presented with fever, fatigue, loss of appetite, and shortness of breath five days after a previous SARS-CoV-2 infection. He had signs of inflammation in multiple organs including the eyes, tongue, skin, and lungs. Based on his symptoms meeting criteria for multisystem inflammatory syndrome in adults (MIS-A) and Kawasaki disease, he was given treatments including steroids, aspirin, and immunoglobulins, which led to rapid improvement. His case suggests MIS-A, a post-viral inflammatory condition primarily described in children, can also occur in older adults.
This document summarizes the potential neurological effects of COVID-19, known as "long COVID". It discusses how the immune response to SARS-CoV-2 infection can lead to neuroinflammation and dysregulation of glial and neuronal cells. This in turn can disrupt neural circuits and cause cognitive impairment. Specifically, reactive microglia can impair mechanisms like myelin homeostasis, oligodendrocyte generation, and synaptic plasticity. Studies show over 70% of COVID patients experience persistent neurological symptoms, with cognitive dysfunction affecting 25%. This suggests COVID-19 may be a major contributor to an emerging neurological health crisis.
This study investigated the clinical features of headaches in 102 patients with long COVID. It found that patients with pre-existing headaches experienced longer headaches during long COVID compared to before infection. Those with headaches had higher disability levels and were more likely to develop chronic headaches. Factors associated with headaches in long COVID included hospitalization, back pain, insomnia, and numbness. The study aims to better understand the characteristics and risk factors of headaches for patients experiencing long COVID.
Long covid, or prolonged symptoms after a COVID-19 infection, is common and can present in a variety of ways. The main approaches to managing long covid in primary care include supportive and holistic care focused on symptom control and detecting treatable complications. Fatigue is the most common symptom, and management focuses on pacing activities and symptom triggers. While the exact causes of long covid are unknown, it is thought to involve chronic inflammation and microvascular damage in multiple organ systems. Many long covid patients can be effectively supported in primary care, though specialist referrals are needed in some cases.
Long COVID, which affects at least 10% of people who have had COVID-19, can last for years and cause over 200 symptoms that impact multiple organ systems. The review summarizes the major findings from research on Long COVID, including immune dysregulation and viral persistence, vascular and organ damage, as well as diagnostic and treatment challenges. It recommends prioritizing clinical trials to address leading hypotheses and ensuring research accounts for biases and testing issues while meaningfully engaging patients.
This presentation summarizes polycystic ovarian syndrome (PCOS). PCOS is a complex hormonal disorder common in women of reproductive age, characterized by enlarged ovaries with small cysts, irregular periods, and excess androgen. The presentation covers the definition, types (including inflammatory, post-pill, insulin resistance and adrenal types), risk factors, symptoms, diagnostic evaluation, and management of PCOS which includes lifestyle changes, medication, and surgery.
The document describes the process for selecting the German team for the International Chemistry Olympiad (IChO), which involves 4 rounds of testing. Students first complete problems at home, then the top scorers advance to chemistry camps involving theoretical and practical exams. The top 15 students then participate in a final week-long practical training camp, after which the IChO team is selected. The document also provides the problems and solutions for each round of the national competition.
1. Evaluarea nivelului de educa釘ie 樽n
domeniul snt釘ii sexuale i
reproductive 樽ntr-o popula釘ie adult
fertil de sex feminin din mediul urban
Elena Popa , Dan Pletea, Gabriel Calfa, Agnes Bacusc ,
Mihaela Boanc, Monica Ungureanu, Delia Matei , Andrei Robil,
Livia Constantinescu, Ioana Crauciuc, Ioana Pvaleanu , Lumini釘a
Avarvarei , Adriana Dima, Andrei Popa
1
2. Introducere
Sanatatea reproductiva se defineste ca o stare de
bunstare fizic, emoional, mental i social
completa , care nu poate fi definit doar prin absen釘a
bolii sau infirmit釘ii i care este legat de tot ce 釘ine de
sistemul de reproducere, func釘iile i procesele
樽ndeplinite de acesta pe parcursul 樽ntregii vie釘i a
omului.
Educaia din domeniul snt釘ii sexuale i
reproductive 樽mbogete cunotinele i
contientizeaza populatia de v但rsta fertil , av但nd ca
urmare 樽nelegerea propriilor drepturi i
responsabiliti.
2
3. Scopul lucrarii
Evaluarea nivelului de
cunotin釘e referitoare la
sanatatea sexuala si
planning familial intr-o
popula釘ie adult fertil de
sex feminin.
3
4. Material si metoda
Studiul pilot a fost efectuat la nivelul a 7
cabinete de medicin de familie din municipiul
Iai 樽n perioada 15.01.2018 - 15.02.2018 .
Criterii de includere in lotul de studiu:
- sex feminin
- varsta 18-49 ani
- participarea la studiu pe baza consim釘m但ntului
liber informat
Subiec釘ii au completat un chestionar referitor la
planificare familial, infec釘ii cu transmitere
sexual , utilizand modele din literatura de
specialitate ( Javorski & Carey-2007 STD-KQ;
Ghinescu M 2009; Drago F et al-2016).
Chestionarele completate au fost introduse intr-
o baz de date Excel i prelucrate statistic. 4
5. Rezultate si discutii lotul de studiu
Lotul de studiu a fost constituit
din 204 femei cu varsta medie de
36,57 賊 8,11 ani
22%
40%
38%
18-29 ani 30-39 ani
40-49 ani
66%
8%
3%
23%
Casatorita Divortata
Concubinaj Necasatorita
4%
46%
50%
Studii
gimnaziale
Studii medii
Studii
superioare
5
6. Ce mijloace de contracepie cunoasteti ?
124
184
52
102
195
114 105
69
126
75
80
20
152
102
9
90 99
135
78
129
Da Nu
DIU
Contraceptive
orale
Plasture
transdermic
Inel
vaginal Prezervativ
Gelul
spermicid
Coitus
intrerruptus
Contraceptia
de urgenta Abstinenta
Contraceptive
injectabile
60,78% 90,19% 25,49% 50% 95,58% 55,88% 51,47% 33,82% 61,76% 36,76%
6
7. Ce mijloace de contraceptie ati utilizat?
8%
18%
47%
12%
4%
7%
2%
2%
Nu am utilizat
Pilula
contraceptiva
Prezervativul
Abstinenta
Inelul vaginal
DIU
Contraceptia de
urgenta
Coitus
intrerruptus
Johnson Sarah et al. Current methods and attitudes of women towards contraception in
Europe and America. Reproductive Health, 2013; 10(1):1
7
CO 35% Spania; 63% Germania
Prez: 20% Germania; 47% Spania
8. 8%
18%
47%
12%
4% 7%
2% 2%
Nu am utilizat
Pilula
contraceptiva
Prezervativul
Abstinenta
Inelul vaginal
DIU
Contraceptia de
urgenta
Coitus
intrerruptus
8
9. De la ce medici ati obtinut informatii si/sau
retete de contraceptive?
Medic
ginecolog
56%
Medic de
familie
9%
Cabinet
planning
familial
6%
Nu am
solicitat
29%
Johnson Sarah et al. Current methods and attitudes of women towards contraception in Europe and
America. Reproductive Health, 2013; 10(1):1
9
10. A. De unde ati obtinut contraceptivele?
B. Cum apreciati costul acestor metode ?
52%
18%
6%
24%
A.
Farmacie Medic ginecolog
Cabinet planning Nu am solicitat
49%
6%
6%
39%
B.
Acceptabil Ieftin
Scump Nu am o parere
10
11. I.1. Care din urmatoarele boli pot fi transmise pe cale sexuala : HIV, sifilis,
hepatita A, hepatita B, hepatita C, infectia cu virus herpetic , candidoza,
condilomatoza genitala (vegetatii veneriene).
Raspuns corect (%)
HIV Sifilis Hep B Hep C
Herpes
simplex Candidoza Condilomatoza
95,58% 86,27% 57,35% 60,29% 51,47% 65,19% 51,47%
0
50
100
150
200
250
Nu stiu
Incorect
Corect
21%
79%
Corect
Incorect
11
12. Cum se dobandeste o boala cu transmitere
sexuala?
Corect
85%
Incorect
5%
Nu stiu
10%
12
13. Ce mijloace de contraceptie protejeaz 樽mpotriva
bolilor cu transmitere sexuala?
73%
3%
18%
6%
Raspuns corect: Prezervativ si/sau
abstinenta
Prezervativ Abstinenta
Prezervativ + abstinenta Raspuns incorect
https://jeffreysterlingmd.files.wordpress.com
13
14. Care sunt fluidele corporale cu risc crescut de
transmitere a infectiei HIV?
Raspuns Numar pacienti (%)
Sange + sperma+ secretii vaginale 18 (8,82%)
Sange 129 ( 63,23%)
Sperma 89 (43,62%)
Secretii vaginale 37(18,13%)
Lapte matern 7 (3,43%)
Saliva (incorect) 36 (17,54%)
Nu stiu 52 (25%)
14
15. Tipul de expunere Risk per/10,000 expuneri
Parenteral
Transfuzie de sange 9,000
Portajul seringilor utilizate pentru iinjectarea drogurilor 67
Percutana (ace contaminate) 30
Sexual
Contact sexual anal receptive 50
Contact sexual heterosexual receptiv 10
Contact sexual anal insertiv 6.5
Icontact sexual heterosexual insertive 5
Contact sexual oral inseriv sau receptiv scazut
Transmitere verticala mama-fat 2, 260
Altele
Muscatura neglijabil
Sputa neglijabil
Jucarii sexuale neglijabil
Patel P, Borkowf CB, Brooks JT. Et al. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014.
https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html
15
17. In caz de suspiciune de boala sexuala, consultati (va
rugam sa bifati o singura varianta):
31%
62%
0% 7% 0%
Medic de familie
Medic ginecolog
Farmacie
Medic dermatolog
17
18. Care dintre urmtoarele infecii sunt potenial
carcinogene? Alegeti dintre : sifilis, candidoz i HPV
0%
50%
100%
Sifilis Candidoza HPV
Corect Incorect Nu stiu
Corect Incorect Nu stiu
Sifilis 132 (64,70%) 31 (15,19%) 41 (20,09%)
Candidoza 157 (76,96%) 6 (2,94%) 41 (20,09%)
HPV potential
carcinogen 144 (70,58%) 19 (9,31%) 41 (20,09%)
18
19. Care dintre bolile cu transmitere sexuala pot fi
prevenite prin vaccinare?
0%
50%
100%
Hepatita B HPV
Corect Incorect Nu stiu
Raspuns corect se pot preveni prin vaccinare:
Hepatita B HPV
39,70 % 41,66%
19
20. A. HPV poate provoca vegetatii veneriene ? (III.12)
B. HPV poate cauza cancer la om ? (III.14)
46%
5%
49%
A.
Raspuns corect (Da)
Raspuns incorect (Nu)
Nu stiu
59%
10%
31%
B.
Raspuns corect (Da)
Raspuns incorect (Nu)
Nu stiu
20
21. A. Exista vaccin eficient pentru hepatita B?(III.25)
B. Vaccinarea anti-HPV protejeaza impotriva CCU? (III.26)
66%
5%
29%
B.
Raspuns corect (Da)
Raspuns incorect (NU)
Nu stiu
67%
8%
25%
A.
Raspuns corect (Da)
Raspuns incorect (Nu)
Nu stiu
21
26. Infectia cu virusul Herpes simplex
- HSV-1-herpesul oral
(transmis predominant
oral), dar in anumite
situatii poate
determina si leziuni la
nivel genital
- HSV-2- herpesul
genital (transmis
exclusiv sexual )
- transmisia HSV -2 pe
cale sexuala este
diminuata de utilizarea
prezervativului
Este posibila si transmiterea
verticala
26
27. Gravidele pot fi testate gratuit pentru sifilis, hepatita B, hepatita
C, HIV in timpul sarcinii?
75%
8% 17%
Raspuns corect (Da)
Raspuns incorect (Nu)
Nu stiu
27
29. Concluzii
1. Sntatea sexual i reproductiva reprezint subiecte dificil de
abordat pentru popula釘ia studiat.
2. Creterea disponibilitatii /ofertei de servicii de PF/SR ar contribui la:
scderea numrului de sarcini nedorite i, consecutiv, a numrului de
avorturi i a patologiei ginecologice legate de avort
reducerea inciden釘ei cancerului genital (樽n special a cancerului de col uterin)
reducerea inciden釘ei infec釘iilor cu trasmitere sexual.
https://www.healthhub.sg
29
#5: Drago F, Ciccarese G, Zangrillo F, et al. A Survey of Current Knowledge on Sexually Transmitted Diseases and Sexual Behaviour in Italian Adolescents. Tchounwou PB, ed.油International Journal of Environmental Research and Public Health. 2016;13(4):422. doi:10.3390/ijerph13040422.
#8: Contraceptive pill use varied between 35% in Spain and 63% in Germany and use of condoms varied between 20% in Germany and 47% in Spain. The contraceptive pill was the most commonly used method in all countries except Spain, where condoms were more commonly the method of choice.油
#12: Prima intrebare s-a referit la recunoaterea bolilor care ar putea fi transmis sexual. Subiecii au fost rugai s selecteze dintr-o list de boli (inclusiv HIV, sifilis, hepatita A, hepatita B, hepatita C, infectia cu herpes simplex, condiloamele si condiloamele genitale) cele pe care le consider a fi transmise sexual. Doar 42 subiecti (21 %) au rspuns corect ptr toate BTS investigate . HIV a fost corect recunoscuta ca STD de ctre 95% dintre participanti, 樽n timp ce 86,27% au recunoscut corect sifilisul ca BTS- ul. Ingrijorator este faptul ca pentru hepatitele B si C nu este incluse in STI de mai mult de 40 % din subiecti. Referitor la condilomatoza si herpes simplex, observam ca putin peste jumatate din subiecti au inclus aceasta aectiune in randul STI.
#16: Patel P, Borkowf CB, Brooks JT. Et al. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014.
https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html
#19: 20 % - nu poseda cunostinte referitoare la aceasta intrebare
70 % au indicat corect HPV ca si potential carcinogen
#20: Raspunsuri gresite: hepatita A 3 , hepatita C 4 , HIV- 5 , Herpes Simplex 5, Sifilis -2, Nici una -5.
#21: Infectia HPV nu este cunoscuta ca o BTS ; HPV este recunoscut ca si potential carcinogen, dar mai putin ca si BTS.
Sunt necesare masuri care sa vizeze preventia primara a CCU: educatie sexuala, vaccinare.
#22: Calea de transmitere sexuala a VHB este mai putin cunoscuta ( Hep B nu a fost mentionata decat de 39 % dintre participanti la intrebarea referitoare la vaccinarea contra BTS)
Infectia cu HPV - carcinogena (70% au raspuns corect), deci vaccinarea anti HPV poate proteja impotriva CCU . HPV nu a fost mentionata decat de cca 40 % la intrebarea referitoare la vaccinarea contra BTS;
Peste 30 % din femei nu cunosteau raspunsul referitor la vaccinuri
#23: In EU/EEA, pentru HBV, prevalena 樽n populaia general a variat de la 0,1% 樽n Irlanda la 4,4% 樽n Rom但nia;
Pentru VHC prevalena 樽n populaia general a fost relativ ridicat (3,2%);
#24: Chronic HBV infection occurs among about 90% of infants infected at birth, 25-50% of children infected at 1-5 years of age and about 1-10% of persons infected as older children and adults (in absenta profilaxiei)
#28: 25 % din femei nu sunt informate cu privire la posibilitatea testarii gratuite in sarcina pentru o parte din BTS.